Skip to main content
SpringerLink
Log in

Cadherin 5 and Annexin V as Circulating Endothelial Microparticles: Markers for Atherosclerotic Vascular Lesions in Patients with Chronic Renal Failure

  • Published:
Kidney

Abstract

Cardiovascular disease is the leading cause of death in Chronic kidney disease patients. This study tries to identify circulating endothelial microparticles {MPs} [such as Cadherin 5 and Anexin V] in CKD patients with and without IHD as potential new risk factors of atherosclerotic vascular disease. This study was carried out in Theodor Bilharz Research Institute [TBRI] on 60 patients with chronic kidney disease on maintenance hemodialysis. They were 41 male and 19 females selected from hemodialysis unit in TBRI. They were further subclassified into the following two groups according to the Echocardiography and Electrocardiogram (ECG) to 25 patients of chronic kidney disease without cardiac complications (17 males, 8 females and ages were 53.5 ± 9.9 years) and 35 patients of chronic kidney disease with cardiac complications (24 males, 11 females and ages were 57.5 ± 7.4 years). Twenty healthy subjects were selected as healthy control, their age 50 ± 9 years. Cadherin 5 & Annexin V Were done by enzyme linked immunosorbant assay (ELISA). The mean cadherin 5 levels in CKD with ischemic HD, CKD without ischemic HD and control group were 86.99 ± 21.51, 33.21 ± 8.65 and 2.63 ± 1.47 respectively which significantly higher in CKD with ischemic HD and CKD without ischemic HD than control group (p < 0.01) and significantly higher in CKD with ischemic HD than CKD without ischemic HD (p < 0.01). As regard to the mean annexin v levels in CKD with ischemic HD, CKD without ischemic HD and control group were 83.73 ± 22.64, 28.51 ± 9.73 and 0.47 ± 0.36 respectively which significantly higher in CKD with ischemic HD and CKD without ischemic HD than control group (p < 0.01) and significantly higher in CKD with ischemic HD than CKD without ischemic HD (p < 0.01). Endothelial dysfunction leading to atherosclerotic vascular disease in patients with CKD can be assessed quantitatively by measurement of plasma levels of endothelial microparticles such as CD144-EMP (Cadherin 5) and Annexin V.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Edward M, Laufer PM, Jagat R, Hofstra NL. Annexin 5: an imaging biomarker of cardiovascular risk. Basic Res Cardiol. 2008;103:95–104.

    Article  Google Scholar 

  2. Annuk M, Soveri I, Zilmer M, Lind L, Hulthe J, Fellstrom B. Endothelial function, CRP and oxidative stress in chronic kidney disease. J Nephrol. 2005;18(6):721–6.

    CAS  PubMed  Google Scholar 

  3. Stam F, van Guldener C, Becker A, Dekker JM, Heine RG, Bouter LM, et al. Endothelial dysfunction contributes to renal insufficiency: the Hoorn study. J Am Soc Nephrol. 2006;17(2):537–45.

    Article  CAS  PubMed  Google Scholar 

  4. Suzuki M, Takamisawa I, Suzuki K, Hiuge A, Horio T, Yoshimasa Y, et al. Close association of endothelial dysfunction with insulin resistance and carotid wall thickening in hypertension. Am J Hypertens. 2004;17(3):228–32.

    Article  CAS  PubMed  Google Scholar 

  5. Migliacci R, Becattini C, Pesavento R, Davi G, Vedovati MC, Guglielmini G, et al. Endothelial dysfunction in pateints with spontaneous venous thromboembolism. Haematological. 2007;92(6):812–8.

    Article  CAS  Google Scholar 

  6. Zoppini G, Targher G, Zamboni C, Venturi C, Cacciatori V, Moghetti P, et al. Effects of moderate-intensity exercise training on plasma biomarkers of inflammation and endothelial dysfunction in older pateints with type 2 diabetes. Nutr Metab Cardiovasc Dis. 2006;16(8):543–9.

    Article  CAS  PubMed  Google Scholar 

  7. Takeichi M. Cadherins: a molecular family important in selective cell-cell adhesion. Annu Rev Biochem. 1990;59:237–52.

    Article  CAS  PubMed  Google Scholar 

  8. Soeki T, Tamura Y, Shinohara H, Sakabe K, Onose Y, Fukuda N. Elevated concentration of soluble vascular endothelial cadherin is associated with coronary atherosclerosis. Circ J. 2004;68(1):1–5.

    Article  CAS  PubMed  Google Scholar 

  9. Preston RA, Jy W, Jimenez JJ. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension. 2003;41:211–7.

    Article  CAS  PubMed  Google Scholar 

  10. Werner N, Wassmann S, Ahlers P, Kosiol S, Nickenig G. Circulating CD31/Anexin V apoptotic microparticles correlates with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2006;26(1):112–6.

    Article  CAS  PubMed  Google Scholar 

  11. Kaneko N, Matsudda R, Hosoda S, Kajita T, Ohta Y. Measurement of plasma Annexin V by ELISA in early detection of acute myocardial infarction. Clin Acta Path. 1996;251(1):65–80.

    CAS  Google Scholar 

  12. Funakoshi T, Heimark RL, Hendrickson LE, McMullen BA, Fujikawa K. Human placental anticoagulant protein: isolation and characterization. Biochemistry. 2001;26:5572–8.

    Article  Google Scholar 

  13. Yao Q, Pecoits-Filho R, Lindholm B, Stenvinkel P. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease. Scand J Urol Nephrol. 2004;38:405–16.

    Article  PubMed  Google Scholar 

  14. Dschietzig T, Richter C, Bartsch C, Böhme C, Heinze D, Ott F, et al. Flow-induced pressure differentially regulates endothelin-1, urotensin II, adrenomedullin, and relaxin in pulmonary vascular endothelium. Biochem Biophys Res Commun. 2002;289(1):245–51.

    Article  Google Scholar 

  15. Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis. 2000;35(4 suppl 1):S117–31.

    Article  CAS  PubMed  Google Scholar 

  16. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115–26.

    Article  CAS  PubMed  Google Scholar 

  17. Widlansky ME, Gokce N, Keaney Jr JF, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003;42:1149–60.

    Article  CAS  PubMed  Google Scholar 

  18. Leroyer A, Mallat Z, Nguyen C, Boddaert J, London GM, Tedgui A, et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol. 2005;16:3381–8.

    Article  PubMed  Google Scholar 

  19. Modena MG, Bonetti L, Coppi F, Bursi F, Rossi R. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol. 2002;40:505–10.

    Article  PubMed  Google Scholar 

  20. Nozaki T, Sugiyama S, Koga H, Sugamura K, Ohba K, Matsuzawa Y, et al. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. J Am Coll Cardiol. 2009;54(7):601–8.

    Article  PubMed  Google Scholar 

  21. Amabile N, Heiss C, Real WM, Minasi P, McGlothlin D, Rame EJ, et al. Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. Am J Respir Crit Care Med. 2008;177:1268–75.

    Article  CAS  PubMed  Google Scholar 

  22. Jimenez JJ, Jy W, Mauro LM, Soderland C, Horstman LL, Ahn YS. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res. 2003;109:175–80.

    Article  CAS  PubMed  Google Scholar 

  23. Bulut D, Tüns H, Mügge A. CD31+/Annexin V+ microparticles in healthy offsprings of patients with coronary artery disease. Eur J Clin Investig. 2008;39(1):17–22.

    Article  Google Scholar 

  24. Bernard S, Loffroy R, Sérusclat A, Boussel L, Bonnefoy E, Thévenon C, et al. Increased levels of endothelial microparticles CD144 (VE-Cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetector computed tomography (MDCT). Atherosclerosis. 2009;203(2):429–35.

    Article  CAS  PubMed  Google Scholar 

  25. Faure V, Dou L, Sabatier F, Cerini C, Sampol J, Berland Y, et al. Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost. 2006;4:566–73.

    Article  CAS  PubMed  Google Scholar 

  26. Ravassa S, Bennaghmouch A, Kenis H, Lindhout T, Hackeng T, Narula J, et al. Annexin A5 down-regulates surface expression of tissue factor: a novel mechanism of regulating the membrane receptor repertoire. J Biol Chem. 2009;280:6028–35.

    Article  Google Scholar 

  27. Tits LJ, Graaf J, Toenhake H, Heerde W, Stalenhoef A. C-reactive protein and annexin A5 bind to distinct sites of negatively charged phospholipids present in oxidized low-density lipoprotein. Arterioscler Thromb Vasc Biol. 2005;25:717–22.

    Article  PubMed  Google Scholar 

  28. Aikawa M, Libby P. The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach. Cardiovasc Pathol. 2004;13:125–38.

    Article  PubMed  Google Scholar 

  29. Cederholm A, Svenungsson E, Jensen-Urstad K, Trollmo C, Ulfgren AK, Swedenborg J, et al. Decreased binding of annexin V to endothelial cells: a potential mechanism in atherothrombosis of patients with systemic lupus erythematosus. Arterioscler Thromb Vasc Biol. 2008;25:198–203.

    Google Scholar 

  30. Jy W, Jimenez JJ, Mauro LM, Horstman LL, Cheng P, Ahn ER, et al. Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation. Thromb Haemost. 2005;3:1301–8.

    Article  CAS  Google Scholar 

  31. Zoccali C. Arterial pressure components and cardiovascular risk in end-stage renal disease. Nephrol Dial Transplant. 2003;18:249–52.

    Article  PubMed  Google Scholar 

  32. Boulanger CM, Amabile N, Tedqui A. Circulating microparticles: Potential prognostic marker for atherosclerotic vascular disease. Hypertension. 2006;29:156–213.

    Google Scholar 

  33. Nakajimi T, Schulte S, Warrington KJ. T-cell mediated lysis of endothelial cells in acute coronary syndromes. Circulation. 2002;105:570–5.

    Article  Google Scholar 

  34. Krane V, Wanner C. Dyslipidaemia in chronic kidney disease. Minerva Urol Nefrol. 2007;59(3):299–316.

    CAS  PubMed  Google Scholar 

  35. Zamboli P, De Nicola, Mioutolo R (2007) Heart failure in chronic kidney disease from epidemiology to therapy. G Ital Nefrol Nov–Dec 24 (6):574–83.

  36. Ix JH, Shlipak MG, Liu HH, Schiller NB, Whooley MA. Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: the heart and soul study. J Am Soc Nephrol. 2003;14(12):3233–8.

    Article  PubMed  Google Scholar 

  37. Nardi E, Cottone S, Mulè G, Palermo A, Cusimano P, Cerasola G. Influence of chronic renal insufficiency on left ventricular diastolic function in hypertensives without left ventricular hypertrophy. J Nephrol. 2007;20(3):320–8.

    CAS  PubMed  Google Scholar 

  38. Kimura T, Iio K, Obi Y, Hayashi T. Left ventricular hypertrophy in predialysis chronic kidney disease: impact of cardiomuscular stress markers. Nippon Jinzo Gakkai Shi. 2007;49(8):1007–13.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medicine, Clinical Pathology Department, Cairo University, Cairo, Egypt

    Mohammed Shehata & Dina El Abd

  2. Clinical Chemistry Department, Theodor Bilharz Research Institute, Cairo, Egypt

    Faten El Shanawani, Mahmoud Farok Moghazy & Afaf Ahmed Abdel Hadi

  3. Nephrology Department, Theodor Bilharz Research Institute, Cairo, Egypt

    Emad Ali Abdallah

  4. Intensive Care Department, Theodor Bilharz Research Institute, Cairo, Egypt

    Hesham Darwish & Amna Metwaly

Authors
  1. Mohammed Shehata
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dina El Abd
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Faten El Shanawani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Emad Ali Abdallah
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hesham Darwish
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mahmoud Farok Moghazy
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Amna Metwaly
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Afaf Ahmed Abdel Hadi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emad Ali Abdallah.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shehata, M., El Abd, D., El Shanawani, F. et al. Cadherin 5 and Annexin V as Circulating Endothelial Microparticles: Markers for Atherosclerotic Vascular Lesions in Patients with Chronic Renal Failure. Kidney 19, 307–315 (2010). https://doi.org/10.1007/s00596-010-0176-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00596-010-0176-0

Keywords

Search

Navigation